Aerovate Therapeutics/$AVTE
About Aerovate Therapeutics
Ticker
Industry
Employees
AVTE Metrics
$72M
-
-$2.98
1.00
-
Price and volume
Market cap
$72M
Beta
1
52-week high
$32.42
52-week low
$1.25
Average daily volume
202K
Financial strength
Current ratio
8.784
Quick ratio
8.602
Long term debt to equity
0.101
Total debt to equity
0.671
Management effectiveness
Return on assets (TTM)
-48.67%
Return on equity (TTM)
-82.06%
Valuation
Price to book
0.9
Price to tangible book (TTM)
0.9
Price to free cash flow (TTM)
-0.945
Growth
Earnings per share change (TTM)
8.74%
3-year earnings per share growth (CAGR)
0.11%
What the Analysts think about AVTE
Analyst Ratings
AVTE Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
AVTE Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
AVTE News
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
FAQs
What’s the current market cap for Aerovate Therapeutics stock?
What is the P/E ratio for Aerovate Therapeutics stock?
Does Aerovate Therapeutics stock pay dividends?
No, Aerovate Therapeutics (AVTE) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Aerovate Therapeutics dividend payment date?
Aerovate Therapeutics (AVTE) stock does not pay dividends to its shareholders.
What is the beta indicator for Aerovate Therapeutics?
Aerovate Therapeutics (AVTE) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.